PregLem Company
![](/files/companies/PregLem.png)
PregLem is a Swiss biopharmaceutical company that focuses on developing and selling innovative drugs for women's reproductive medicine.
Headquarters:
Geneva
Industry:
Reproductive Health & Contraception
Employee Number:
11-50
Investors Number:
4
Funding Status:
M&A
Last Funding Type:
Series B
Founded Date:
2006
Total Funding:
$58,248,124
Last Funding Date:
2007-12-04